Canada Pension Plan Investment Board (CPP Investments)

Money Moves

Participating in the takeover offer

Swedish buyout firm EQT Private Equity agreed to buy Dutch molecular testing company QIAGEN for €46.50 a share in cash, valuing it at about $12.1 billion including roughly $1.1 billion of net debt. The price is 40.3% above QIAGEN's €33.15 close on July 8, the last trading day before reports of private equity interest surfaced.

Updated Oct 23

New Capabilities

As of September 2026: Co-investor in Beeline's Series A

Beeline Medicines' afimetoran, a once-daily oral pill for lupus, met its primary endpoint in a Phase 2 trial. The result moves the biotech into Phase 3 (pivotal) development for two forms of the disease.

Updated Sep 9

Money Moves

As of May 2026: Indirect seller via 90% Teine ownership

Canada's most important crude staging hub just got more concentrated. On May 1, Gibson Energy closed a C$400 million purchase of a 75-kilometer gathering pipeline from oil producer Teine Energy, then immediately sanctioned a project to wire those barrels directly into its Hardisty terminal. The Alberta facility already handles roughly one in four barrels exported from Western Canada.

Updated May 31

Money Moves

As of May 2026: Participant in 9fin Series C

Credit markets move roughly $140 trillion in outstanding debt worldwide, yet analysts who price, trade, and monitor that debt spend much time reading 300-page loan agreements and hunting for pricing data through calls and chats. 9fin, a London-based startup founded by two former investment bankers, just raised $170 million at a $1.3 billion valuation to automate that work with artificial intelligence. The round crosses the unicorn threshold, signaling that institutional investors treat AI-driven credit analytics as proven technology.

Updated May 30